Overview
Affidea Polska operates 43 medical facilities in 31 cities and has provided imaging diagnostics and oncology treatment for more than 20 years. Its services include MRI, CT, PET/CT, pathomorphological and molecular diagnostics, and clinical trials. The company serves patients through NFZ reimbursement and privately, and its network also includes radiotherapy centers and oncology clinics.
Financials
The financial statement for 2025 has not yet been filed with the Financial Document Repository (past deadline).
Revenue history (in m)
Data and insights are generated automatically based on financial statements and may contain errors. This analysis is for informational purposes only and does not constitute an official assessment of the company's credibility or business advice.
Statistics
How the company ranks by revenue within its industry, region and across Poland in 2024.
Results vs industry
Industry
Bank accounts
Registered as a VAT taxpayer on 2007-03-01. Active
48 1240 6292 1111 0011 3172 8126- 75 1240 6292 1978 0011 3172 8328
Debt
No entries in the National Debtors Register (KRZ). No proceedings in KRZ
Public aid
No public aid cases recorded in the last 10 years.
Tenders
No recorded participation in tenders.
National Health Fund (NFZ) contracts
Affidea Onkoterapia has been an NFZ healthcare provider since 2008. In 2026 it is performing 2 contracts with a total value of USD 15.53m. All its contracts were worth USD 120.58m in total.
NFZ contract value by year (in m USD)
| Type of care | NFZ branch | Contracts | Value in 2026 |
|---|---|---|---|
| Leczenie szpitalne | zachodniopomorskie | 1 | USD 14.67m |
| Ambulatoryjna opieka specjalistyczna | wielkopolskie | 1 | USD 860.05k |
Regulatory authorisations
| Authority | Type | Status | |
|---|---|---|---|
 BDO | BDO register entry | Active |
Authorized Representatives
Manner of representation
In the case of a one-person management board, the sole member of the management board has the right to represent the company independently. In the case of a multi-member management board, two members of the management board acting jointly are authorised to represent the company.
Ownership
| Owner | Shares | Share value | Stake |
|---|---|---|---|
Affidea Cancer Treatment Centres B.v. | 190,170 | $2,568,476.50 | 100% |
Beneficial owners
| Person | Rights |
|---|---|
Subsidiaries
| Name | Share value | Stake | ||
|---|---|---|---|---|
NU - Med GrupaS.A. | 274,448.27 USD | 100% | ||
European Medical Partnersp. z o.o. | 958.94 USD | 71% |
Competitors
| Name | Revenue | Website | ||
|---|---|---|---|---|
| ScanmedS.A. | $266,523,177.15 | scanmed.pl | ||
| LUX Med Onkologiasp. z o.o. | $121,974,338.96 | onkologia.luxmed.pl | ||
| Mazowiecki Szpital Onkologicznysp. z o.o. | $72,929,509.74 | szpitalonkologiczny.pl | ||
| Centrum Diagnostyki Medycznej Multi-MedS.A. | $14,036,138.38 | multimed.pl | ||
| Eurodiagnosissp. z o.o. | $2,285,077.53 | eurodiagnosis.pl | ||
| Quadiasp. z o.o. + limited partnership | $2,151,119.92 | quadia.pl | ||
| InterfizjoS.A. | $1,113,889.61 | interfizjo.pl | ||
| OBER Clinicsp. z o.o. | $1,085,228.69 | oberclinic.pl | ||
| Klinika Sanosp. z o.o. | $188,923.44 | alergoland.pl | ||
| Onkomedicasp. z o.o. | $69,344.55 | onkomedica.pl |
Change history
| Date | Event | |
|---|---|---|
| 2016-08-25 | Address change (Mokotowska 49, 00-542, Warszawa → Plac Europejski 2, 00-844, Warszawa) | |
| 2015-05-11 | Name change (Euromedic Onkoterapia → Affidea Onkoterapia) | |
| 2015-02-20 | Share capital change (5,508,500.00 PLN → 9,508,500.00 PLN) | |
| 2015-02-20 | PKD change (Removed: 33.10.B, 51.46.Z, 51.90.Z, 74.12.Z, 74.13.Z, 74.14.A, 74.14.B, 80.42.B, 85.12.Z, 85.14.F; Added: 33.14.Z, 33.20.Z, 46.46.Z, 46.90.Z, 70.22.Z, 73.20.Z, 85.59.B, 86.10.Z, 86.22.Z, 86.90.E) | |
| 2011-09-15 | Address change (Rondo Onz 1, 00-124, Warszawa → Mokotowska 49, 00-542, Warszawa) |
FAQ
Last updated: 2026-10-07